1. Project
  2. DOWN-AUTONOMY
  3. Organisations

LCTB-21: A DYRK1A protein kinase inhibitor for treatment of cognitive decline in Down Syndrome.

Full project page

Organisations map overview


Powered by Chris Decubber BV